HomeNDC LookupRxCUI directory › RxCUI 308715

Betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Lotion — RxCUI 308715

RxNorm drug concept · Semantic clinical drug
RxCUI 308715 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308715
Official nameBetamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / clotrimazole 1 % Topical Lotion; clotrimazole 1 % / betamethasone dipropionate 0.05 % Topical Lotion
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)5,470 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clotrimazole Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clotrimazole treats several types of fungal infections, depending on the form you're using. The cream or solution is used on the skin for things like athlete's foot, ringworm, and...
  • What kinds of infections does clotrimazole treat?
  • No — the lozenge needs to dissolve slowly in your mouth, so don't chew it or swallow it whole. The whole point is to keep the medicine in contact with the mouth and throat lining a...
  • How do I use the lozenge — can I just swallow it?
📖 Read our full Clotrimazole Topical guide →

🕸️ Concept Web — How Betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Lotion RxCUI 308715

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Betamethasone 1514
    • Clotrimazole 2623
    • Betamethasone / clotrimazole 106928
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Betamethasone / clotrimazole Topical Lotion 379106
    • Betamethasone / clotrimazole Topical Product 1153768
    • Topical Lotion 316983
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Betamethasone 0.5 MG/ML 340130
    • Clotrimazole 10 MG/ML 340084

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Betamethasone 0.5 MG/ML SCDC · 340130
  • Clotrimazole 10 MG/ML SCDC · 340084
  • Betamethasone / clotrimazole Topical Lotion SCDF · 379106
  • Betamethasone / clotrimazole Topical Product SCDG · 1153768

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 308715 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51672-1308-03 1 BOTTLE in 1 CARTON (51672-1308-3) / 30 mL in 1 BOTTLE Clotrimazole and Betamethasone Dipropionate Sun Pharmaceutical Industries, Inc. 2004-07-28
Observed labelers: Sun Pharmaceutical Industries, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$3.0075
Range $3.0075–$3.0075 · middle 50% $3.0075–$3.0075 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.